Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial.

J Am Heart Assoc · 2021 · PMC8649516 · PMID 34533034

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

a statistical trendP =0.061so close (0.05 < p ≤ 0.1)

There was a statistical trend towards less target vessel revascularization in the experimental arm in the ACS (4.51% versus 5.46%; RR, 0.82; 95% CI, 0.67–1.01; P =0.061) but not the SCAD subgroup (5.20% versus 5.60%; RR, 0.93; 95% CI, 0.78–1.12; P =0.446), but the test for interaction was again negative ( P ‐int=0.379).

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.